Landscape Capital Management L.L.C. Raises Holdings in Encompass Health Corporation $EHC

Landscape Capital Management L.L.C. lifted its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 114.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 33,740 shares of the company’s stock after acquiring an additional 18,014 shares during the period. Landscape Capital Management L.L.C.’s holdings in Encompass Health were worth $3,581,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of EHC. WPG Advisers LLC grew its stake in shares of Encompass Health by 73.3% during the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after acquiring an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC purchased a new stake in shares of Encompass Health during the fourth quarter worth about $37,000. Assetmark Inc. grew its stake in shares of Encompass Health by 88.1% during the third quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after acquiring an additional 362 shares during the last quarter. Finally, Covestor Ltd grew its stake in shares of Encompass Health by 24.4% during the fourth quarter. Covestor Ltd now owns 540 shares of the company’s stock worth $57,000 after acquiring an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Trading Up 0.0%

Shares of EHC stock opened at $101.49 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The company has a market cap of $10.07 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 2.21 and a beta of 0.72. The stock has a 50 day simple moving average of $104.31 and a 200-day simple moving average of $104.59. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the prior year, the company earned $1.37 EPS. The firm’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio is currently 12.69%.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on EHC. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. TD Cowen assumed coverage on Encompass Health in a research note on Thursday, May 28th. They set a “buy” rating and a $125.00 price target on the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of Encompass Health in a research report on Monday, June 8th. Barclays dropped their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Finally, Leerink Partners set a $152.00 target price on Encompass Health in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $143.86.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.